Skip to main content
TipRanks
Go Ultimate75% OFF

X L.P. Canaan Insider Profile

4 Followers

X L.P. Canaan , Director, Ten Percent Owner at Iterum Therapeutics, holds ― shares in Iterum Therapeutics (Ticker: ITRMF), holds 16.49M shares in Astra Space (Ticker: ASTR), holds 2.66M shares in IDEAYA Biosciences (Ticker: IDYA).

X L.P. Canaan 's Trading History

ASTR
Astra Space
Jan 04, 2022―Uninformative Sell―$8.89M
IDYA
IDEAYA Biosciences
May 28, 2019Ten Percent OwnerUninformative Buy―$80.78M
NXTC
NextCure
May 13, 2019Ten Percent OwnerUninformative Buy―$15.06M
PTGX
Protagonist Therapeutics
May 21, 2018Ten Percent OwnerInformative Sell237.32K$264.21M
ITRMF
Iterum Therapeutics
―Director, Ten Percent Owner――

You May Also Like

X L.P. Canaan insider profile FAQ

What is the percentage of profitable transactions made by X L.P. Canaan ?
The percentage of profitable transactions made by X L.P. Canaan is 50%.
What is the average return per transaction made by X L.P. Canaan ?
The average return per transaction made by X L.P. Canaan is -4.00%.
What stocks does X L.P. Canaan hold?
X L.P. Canaan holds: ITRMF, PTGX, NXTC, IDYA, ASTR stocks.
What was X L.P. Canaan 's most profitable transaction?
X L.P. Canaan ’s most profitable transaction was an Informative Buy of NXTC stock on May 13, 2019. The return on the trade was 72.10%.
What is X L.P. Canaan 's role in Iterum Therapeutics?
X L.P. Canaan 's role in Iterum Therapeutics is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.